Cargando…

Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study

BACKGROUND: The histologic classification of lung adenocarcinoma (LUAD) was mainly divided into three pathological subtype groups: the low-grade predominant subtype group (lepidic), the intermediate-grade predominant subtype group (papillary and acinar), and the high-grade predominant subtype group...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shuai, Li, Shuman, Li, Jiuzhen, Li, Xin, Ding, Yun, Liu, Xin, Wang, Kai, Shi, Yi, Sun, Daqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840014/
https://www.ncbi.nlm.nih.gov/pubmed/36647489
http://dx.doi.org/10.21037/jtd-22-1524
_version_ 1784869558131097600
author Sun, Shuai
Li, Shuman
Li, Jiuzhen
Li, Xin
Ding, Yun
Liu, Xin
Wang, Kai
Shi, Yi
Sun, Daqiang
author_facet Sun, Shuai
Li, Shuman
Li, Jiuzhen
Li, Xin
Ding, Yun
Liu, Xin
Wang, Kai
Shi, Yi
Sun, Daqiang
author_sort Sun, Shuai
collection PubMed
description BACKGROUND: The histologic classification of lung adenocarcinoma (LUAD) was mainly divided into three pathological subtype groups: the low-grade predominant subtype group (lepidic), the intermediate-grade predominant subtype group (papillary and acinar), and the high-grade predominant subtype group (micropapillary and solid). Previous studies have focused on the prognostic impact of predominant subtypes of lung adenocarcinoma. In this investigation, we investigated the effect of the second predominant subtype on prognosis. METHODS: The data of LUAD postoperative patients were retrospectively collected. Exclusion criteria included cases in which the pathologic results revealed a single characteristic, the presence of invasive mucinous LUAD, or if the first predominant and the second predominant groups could not be distinguished. Categorical variables were compared with the two-tailed Pearson χ(2) test and continuous variables with the Student’s t-test. Follow-up was conducted by telephone and other methods. Independent prognostic factors of the second major subtype were determined by the Kaplan-Meier method and log-rank test. The Cox proportional risk regression model was used to analyze the possible prognostic factors. RESULTS: Among 293 patients, the mean age was 61.9 years and 47.1% were male. The results revealed that when the predominant group was the low-grade group, the second predominant groups had no significant influence on overall survival (OS) (P=0.15) but significantly influenced disease free survival (DFS) (P=0.037). Subsequently, when the predominant group was the intermediate-grade group, the second predominant groups significantly influenced OS (P=0.024) but had no significant influence on DFS (P=0.3). Moreover, when the predominant group was the high-grade group, the second predominant groups significantly influenced OS (P=0.033) but had no significant influence on DFS (P=0.31). CONCLUSIONS: The independent prognostic effect of the second predominant group was not identified for OS and DFS of lung adenocarcinoma. The effects of the second predominant subtype groups on OS and DFS were not evenly distributed among different predominant subtype groups, and the low-grade second predominant subtype exhibited some protective effects on the middle-grade predominant subtypes.
format Online
Article
Text
id pubmed-9840014
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-98400142023-01-15 Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study Sun, Shuai Li, Shuman Li, Jiuzhen Li, Xin Ding, Yun Liu, Xin Wang, Kai Shi, Yi Sun, Daqiang J Thorac Dis Original Article BACKGROUND: The histologic classification of lung adenocarcinoma (LUAD) was mainly divided into three pathological subtype groups: the low-grade predominant subtype group (lepidic), the intermediate-grade predominant subtype group (papillary and acinar), and the high-grade predominant subtype group (micropapillary and solid). Previous studies have focused on the prognostic impact of predominant subtypes of lung adenocarcinoma. In this investigation, we investigated the effect of the second predominant subtype on prognosis. METHODS: The data of LUAD postoperative patients were retrospectively collected. Exclusion criteria included cases in which the pathologic results revealed a single characteristic, the presence of invasive mucinous LUAD, or if the first predominant and the second predominant groups could not be distinguished. Categorical variables were compared with the two-tailed Pearson χ(2) test and continuous variables with the Student’s t-test. Follow-up was conducted by telephone and other methods. Independent prognostic factors of the second major subtype were determined by the Kaplan-Meier method and log-rank test. The Cox proportional risk regression model was used to analyze the possible prognostic factors. RESULTS: Among 293 patients, the mean age was 61.9 years and 47.1% were male. The results revealed that when the predominant group was the low-grade group, the second predominant groups had no significant influence on overall survival (OS) (P=0.15) but significantly influenced disease free survival (DFS) (P=0.037). Subsequently, when the predominant group was the intermediate-grade group, the second predominant groups significantly influenced OS (P=0.024) but had no significant influence on DFS (P=0.3). Moreover, when the predominant group was the high-grade group, the second predominant groups significantly influenced OS (P=0.033) but had no significant influence on DFS (P=0.31). CONCLUSIONS: The independent prognostic effect of the second predominant group was not identified for OS and DFS of lung adenocarcinoma. The effects of the second predominant subtype groups on OS and DFS were not evenly distributed among different predominant subtype groups, and the low-grade second predominant subtype exhibited some protective effects on the middle-grade predominant subtypes. AME Publishing Company 2022-12 /pmc/articles/PMC9840014/ /pubmed/36647489 http://dx.doi.org/10.21037/jtd-22-1524 Text en 2022 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Sun, Shuai
Li, Shuman
Li, Jiuzhen
Li, Xin
Ding, Yun
Liu, Xin
Wang, Kai
Shi, Yi
Sun, Daqiang
Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study
title Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study
title_full Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study
title_fullStr Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study
title_full_unstemmed Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study
title_short Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study
title_sort prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840014/
https://www.ncbi.nlm.nih.gov/pubmed/36647489
http://dx.doi.org/10.21037/jtd-22-1524
work_keys_str_mv AT sunshuai prognosisofthesecondpredominantsubtypeinlungadenocarcinomaaretrospectivesinglecentercohortstudy
AT lishuman prognosisofthesecondpredominantsubtypeinlungadenocarcinomaaretrospectivesinglecentercohortstudy
AT lijiuzhen prognosisofthesecondpredominantsubtypeinlungadenocarcinomaaretrospectivesinglecentercohortstudy
AT lixin prognosisofthesecondpredominantsubtypeinlungadenocarcinomaaretrospectivesinglecentercohortstudy
AT dingyun prognosisofthesecondpredominantsubtypeinlungadenocarcinomaaretrospectivesinglecentercohortstudy
AT liuxin prognosisofthesecondpredominantsubtypeinlungadenocarcinomaaretrospectivesinglecentercohortstudy
AT wangkai prognosisofthesecondpredominantsubtypeinlungadenocarcinomaaretrospectivesinglecentercohortstudy
AT shiyi prognosisofthesecondpredominantsubtypeinlungadenocarcinomaaretrospectivesinglecentercohortstudy
AT sundaqiang prognosisofthesecondpredominantsubtypeinlungadenocarcinomaaretrospectivesinglecentercohortstudy